Seeking Alpha
View as an RSS Feed

MedTechBio  

View MedTechBio's Comments BY TICKER:

Latest  |  Highest rated
  • Premarket Biotech Digest: Familial Hypercholesterolemia, Dynavax BLA Track, Earnings [View article]
    DVAX's secret weapon in their Toll Like Receptor (TLR) technology of which Hepislav is there first of several products in the pipeline. Though undervalued on Hepislav alone, considering DVAX's pipeline, the price currently is a blinding steal.
    Jul 30, 2015. 09:31 AM | 1 Like Like |Link to Comment
  • Geron's Second-Line Myelofibrosis Trial Offers Significant EPS Potential [View article]
    Plausible
    Jul 29, 2015. 10:56 PM | Likes Like |Link to Comment
  • Gilead Beats And Raises: Thinking Through The Future Of Its Business And Its Stock Price [View article]
    Conatus (CNAT) is an obvious target for GILD. Their lead candidate manages liver disease far after HEP C is cured.
    Jul 29, 2015. 02:08 PM | 3 Likes Like |Link to Comment
  • Geron's Much Anticipated Imetelstat Phase 2 Study Grows To 50 Locations And Begins Enrollment [View article]
    No round lots at all. DVAX, in the meantime is ripping.
    Jul 29, 2015. 11:39 AM | Likes Like |Link to Comment
  • Geron's Much Anticipated Imetelstat Phase 2 Study Grows To 50 Locations And Begins Enrollment [View article]
    Just put through a 5K ATM buy. Clear that all my trades sold to hedge funds shorting to keep the breakout at bay. All partial penny trades broke into 5 trades.
    Jul 29, 2015. 11:39 AM | Likes Like |Link to Comment
  • Trio Of Small Biotechs With Upcoming 2015 Catalysts And Enormous Long-Term Potential [View article]
    DVAX just tearing up the charts. Look for more! GSX may very well buy DVAX $55+, though I hope they don't. We're 100+ in a couple years if independent.
    Jul 29, 2015. 10:34 AM | Likes Like |Link to Comment
  • Geron's Second-Line Myelofibrosis Trial Offers Significant EPS Potential [View article]
    She is real, John in real. Also, given efficacy on all MF mutations and JAK mutations in particular there may in fact be multiple MOAs. We're getting an extended handle on the chart, something is going to break soon.
    Jul 29, 2015. 10:09 AM | 3 Likes Like |Link to Comment
  • Geron's Second-Line Myelofibrosis Trial Offers Significant EPS Potential [View article]
    I believed they paid $25,000 to keep yours, mine and other comments off the site. This happened fall of last year. I can't get a darned thing posted on that site. Pure evil. Can't wait until Imet is finally approved, though I'm sure the battle of good over evil won't be.
    Jul 28, 2015. 12:00 PM | 5 Likes Like |Link to Comment
  • Geron's Much Anticipated Imetelstat Phase 2 Study Grows To 50 Locations And Begins Enrollment [View article]
    Oh boy Chinese stocks cliff diving towards the end of the session. Looks like the premier needs to make a few more phone calls and maybe drag someone out to the square.
    Jul 27, 2015. 07:11 AM | Likes Like |Link to Comment
  • Geron's Much Anticipated Imetelstat Phase 2 Study Grows To 50 Locations And Begins Enrollment [View article]
    User I remember that, I guess they're not pursuing the short TL; at least not yet.
    Jul 27, 2015. 12:15 AM | Likes Like |Link to Comment
  • Geron's Much Anticipated Imetelstat Phase 2 Study Grows To 50 Locations And Begins Enrollment [View article]
    Did we ever get an update on this trial?? NSCLC Imetelstat + Avastin.
    http://1.usa.gov/1IpcAQn
    Jul 26, 2015. 06:50 PM | Likes Like |Link to Comment
  • Geron's Second-Line Myelofibrosis Trial Offers Significant EPS Potential [View article]
    You sure it isn't bed bugs?
    Jul 26, 2015. 10:22 AM | 3 Likes Like |Link to Comment
  • Market Update: Current View Of The 'Secular Bull Market' Amidst The Backdrop Of Fear In The Markets, A View Of The Past, Present And Future [View article]
    I agree Jose (though I'm less sure about the "strong" part. More like range bound for awhile.
    Jul 26, 2015. 08:58 AM | 2 Likes Like |Link to Comment
  • Market Update: Current View Of The 'Secular Bull Market' Amidst The Backdrop Of Fear In The Markets, A View Of The Past, Present And Future [View article]
    Glenn you forgot about nuclear anihilation and Fukushima killing the Pacific ocean in its entirety.
    Jul 25, 2015. 07:06 PM | 1 Like Like |Link to Comment
  • Market Update: Current View Of The 'Secular Bull Market' Amidst The Backdrop Of Fear In The Markets, A View Of The Past, Present And Future [View article]
    "Every time the stock market has broken decisively above the top side of a 10+ years "range-bound" market, it has ALWAYS been the dawn of a new secular bull market. I maintain that this time is no different." ~ You

    "There are no relationships or equations that always work" ~ Barton Biggs


    Just havin' a little fun... :-)
    Jul 25, 2015. 10:56 AM | 12 Likes Like |Link to Comment
COMMENTS STATS
1,566 Comments
1,727 Likes